Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
DVA

DaVita

$52.42

-1.11 (-2.07%)

12:15
03/18/19
03/18
12:15
03/18/19
12:15
Options
DaVita put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Thursday
CVS

CVS Health

$56.55

1.89 (3.46%)

, ACB

Aurora Cannabis

$9.05

1.09 (13.69%)

07:35
03/14/19
03/14
07:35
03/14/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

CVS

CVS Health

$56.55

1.89 (3.46%)

ACB

Aurora Cannabis

$9.05

1.09 (13.69%)

APC

Anadarko

$44.67

0.855 (1.95%)

AIG

AIG

$43.48

0.75 (1.76%)

NLSN

Nielsen

$27.06

0.13 (0.48%)

TTWO

Take-Two

$96.02

6.14 (6.83%)

MRVL

Marvell

$19.70

-0.09 (-0.45%)

DVA

DaVita

$53.59

2.26 (4.40%)

PVTL

Pivotal Software

$22.29

-0.15 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 14

    Mar

  • 25

    Mar

  • 27

    Mar

  • 03

    Apr

  • 10

    Apr

  • 22

    May

Over a week ago
DVA

DaVita

$53.31

1.98 (3.86%)

12:10
03/13/19
03/13
12:10
03/13/19
12:10
Options
Aggressive upside call buyer in DaVita »

Aggressive upside call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$58.12

0.3 (0.52%)

, DVA

DaVita

$57.04

0.07 (0.12%)

08:10
03/04/19
03/04
08:10
03/04/19
08:10
Periodicals
CVS could benefit from kidney disease treatment changes, Reuters reports »

CVS (CVS) could benefit…

CVS

CVS Health

$58.12

0.3 (0.52%)

DVA

DaVita

$57.04

0.07 (0.12%)

FMS

Fresenius Medical

$39.13

0.06 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

Over a month ago
DVA

DaVita

$58.08

0.19 (0.33%)

09:15
02/15/19
02/15
09:15
02/15/19
09:15
Recommendations
DaVita analyst commentary at Baird »

DaVita price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVA

DaVita

$57.89

0.53 (0.92%)

16:46
02/13/19
02/13
16:46
02/13/19
16:46
Earnings
DaVita sees FY19 adjusted operating income $1.54B-$1.64B vs. $1.51B in FY18 »

Sees FY19 effective tax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

DVA

DaVita

$57.89

0.53 (0.92%)

16:44
02/13/19
02/13
16:44
02/13/19
16:44
Earnings
DaVita reports Q4 adjusted EPS 90c, consensus 90c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

DVA

DaVita

$54.03

-0.35 (-0.64%)

09:09
01/09/19
01/09
09:09
01/09/19
09:09
Recommendations
DaVita analyst commentary at RBC Capital »

DaVita price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVA

DaVita

$54.38

0.37 (0.69%)

05:36
01/08/19
01/08
05:36
01/08/19
05:36
Upgrade
DaVita rating change at UBS »

UBS upgrades DaVita to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVA

DaVita

$54.38

0.37 (0.69%)

04:15
01/08/19
01/08
04:15
01/08/19
04:15
Upgrade
DaVita rating change at UBS »

DaVita upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.